Stockreport

INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update

INmune Bio Inc. - Common stock  (INMB) 
PDF BOCA RATON, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on de [Read more]